638 filings
PRE 14A
PDSB
PDS Biotechnology Corporation
Preliminary proxy
18 Apr 24
4:15pm
S-8
PDSB
PDS Biotechnology Corporation
28 Mar 24
Registration of securities for employees
5:26pm
10-K
2023 FY
PDSB
PDS Biotechnology Corporation
Annual report
28 Mar 24
5:16pm
8-K
PDSB
PDS Biotechnology Corporation
27 Mar 24
PDS Biotech Announces Clinical Strategy Update and Reports Full Year 2023 Financial Results
7:30am
8-K
PDSB
PDS Biotechnology Corporation
13 Mar 24
Patent for composition of matter and use of Infectimune® based influenza vaccines granted in the United States
6:02am
SC 13G
0cr8zsy b0e9a
29 Jan 24
PDS Biotechnology / BlackRock ownership change
5:26pm
4
dph84kapqn
23 Jan 24
PDS Biotechnology / Kirk V. Shepard ownership change
4:33pm
3
k9oz5fa4ttgkne m2f
23 Jan 24
PDS Biotechnology / Kirk V. Shepard ownership change
4:31pm
8-K
5o7b92qsrf g2pmfwom
22 Jan 24
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
5:10pm
4
vv86yvsxxobpzqb1i
4 Dec 23
PDS Biotechnology / Lars Boesgaard ownership change
6:14pm
3
4k04l jig805bbaqx
4 Dec 23
PDS Biotechnology / Lars Boesgaard ownership change
6:11pm
8-K
nsxf2qeb
4 Dec 23
Other Events
4:02pm
8-K
yeo8zusicwv n4ou4s
28 Nov 23
PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
6:02am
S-8
u8u9e
14 Nov 23
Registration of securities for employees
4:11pm
8-K
vcg4ww2
14 Nov 23
PDS Biotech Reports Third Quarter 2023 Financial Results and Provides Business Update
12:00am
8-K
5fu21
9 Nov 23
Other Events
4:07pm
8-K
z3yos0
23 Oct 23
PDS Biotech Announces Preliminary Biomarker Study Results in Subset of Advanced HPV-Positive Head and Neck Cancer Patients at ESMO
4:06pm
8-K
pj9itwds61 9it
11 Oct 23
Other Events
4:02pm
8-K
u0swteffbb6 maggqh
3 Oct 23
Other Events
4:03pm